An inadequate biomarker validation can affect many patients' diagnosis, treatment, and follow-up. Therefore, special interest should be placed on performing these analyses correctly so that biomarkers can be applicable to patients and evidence of their clinical usefulness can be generated. A methodological work on the concept of biomarkers is presented, as well as the difficulties associated with the methodological approach to their development, validation, and implementation in clinical practice.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.reumae.2024.07.002 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!